BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Oryza sativa {Rice} - Akkermansia |
📓
Characterization and the cholesterol-lowering effect of dietary fiber from fermented black rice (Oryza sativa L.). Food & function (Food Funct ) Vol: 14 Issue 13 Pages: 6128-6141 Pub: 2023 Jul 3 Epub: 2023 Jul 3 Authors Guan Y , Xie C , Zhang R , Zhang Z , Tian Z , Feng J , Shen X , Li H , Chang S , Zhao C , Chai R , Publication |
| Oryza sativa {Rice} - Akkermansia |
👪
Modified cereal bran (MCB) from finger millet, kodo millet, and rice bran prevents high-fat diet-induced metabolic derangements. Food & function (Food Funct ) Vol: 14 Issue 3 Pages: 1459-1475 Pub: 2023 Feb 6 Epub: 2023 Feb 6 Authors Devi K , Kumar V , Kumar V , Mahajan N , Kaur J , Sharma S , Kumar A , Khan R , Bishnoi M , Kondepudi KK , Publication |
| Oryza sativa {Rice} - Akkermansia |
📓
Arabinoxylan from rice bran protects mice against high-fat diet-induced obesity and metabolic inflammation by modulating gut microbiota and short-chain fatty acids. Food & function (Food Funct ) Vol: 13 Issue 14 Pages: 7707-7719 Pub: 2022 Jul 18 Epub: 2022 Jul 18 Authors Luo S , He L , Zhang H , Li Z , Liu C , Chen T , Publication |
| Oryza sativa {Rice} - Akkermansia |
📓
Rice bran attenuated obesity via alleviating dyslipidemia, browning of white adipocytes and modulating gut microbiota in high-fat diet-induced obese mice. Food & function (Food Funct ) Vol: 11 Issue 3 Pages: 2406-2417 Pub: 2020 Mar 1 Epub: 2020 Mar 4 Authors Zou Y , Ju X , Chen W , Yuan J , Wang Z , Aluko RE , He R , Publication |
| Oryza sativa {Rice} - Akkermansia |
📓
The role of bound polyphenols in the anti-obesity effects of defatted rice bran insoluble dietary fiber: An insight from multi-omics. Food chemistry (Food Chem ) Vol: 459 Issue Pages: 140345 Pub: 2024 Nov 30 Epub: 2024 Jul 5 Authors Zheng B , Zhao X , Ao T , Chen Y , Xie J , Gao X , Liu L , Hu X , Yu Q , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
